These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 15852581

  • 1. Professional pill pusher.
    Meyer CR.
    Minn Med; 2005 Mar; 88(3):4. PubMed ID: 15852581
    [No Abstract] [Full Text] [Related]

  • 2. [One man's loss is another man's gain].
    Laake JH.
    Tidsskr Nor Laegeforen; 2004 Dec 02; 124(23):3095. PubMed ID: 15586198
    [No Abstract] [Full Text] [Related]

  • 3. The pain game.
    Wadman M.
    Nature; 2007 Jul 26; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract] [Full Text] [Related]

  • 4. Captive markets.
    Mettner J.
    Minn Med; 2008 Nov 26; 91(11):12-3. PubMed ID: 19108536
    [No Abstract] [Full Text] [Related]

  • 5. The Vioxx debacle revisited.
    Good CB, Kelley CL.
    Am J Med; 2005 Sep 26; 118(9):1055-6; author reply 1056-7. PubMed ID: 16164902
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Vioxx: reasons for a premature retirement].
    Med Sci (Paris); 2005 Jan 26; 21(1):35. PubMed ID: 15712385
    [No Abstract] [Full Text] [Related]

  • 8. Evaluating drug effects in the post-Vioxx world: there must be a better way.
    Avorn J.
    Circulation; 2006 May 09; 113(18):2173-6. PubMed ID: 16684873
    [No Abstract] [Full Text] [Related]

  • 9. Drug lawsuits building. Merck, Pfizer facing charges of misrepresentation.
    Benko LB.
    Mod Healthc; 2006 Apr 10; 36(15):16. PubMed ID: 16669517
    [No Abstract] [Full Text] [Related]

  • 10. Vioxx removed from market.
    Mayo Clin Womens Healthsource; 2004 Dec 10; 8(12):3. PubMed ID: 15592151
    [No Abstract] [Full Text] [Related]

  • 11. Concern about one drug or entire class of drugs.
    Curković B.
    Reumatizam; 2005 Dec 10; 52(1):5-6. PubMed ID: 16689104
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Vioxx debacle revisited.
    Mohapatra PR, Janmeja AK.
    Am J Med; 2005 Sep 10; 118(9):1058. PubMed ID: 16164909
    [No Abstract] [Full Text] [Related]

  • 14. Painkiller in the dock.
    Nature; 2005 Jul 28; 436(7050):459. PubMed ID: 16049447
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Withdrawal syndrome.
    Nat Med; 2004 Nov 28; 10(11):1143. PubMed ID: 15516887
    [No Abstract] [Full Text] [Related]

  • 17. Tolerance induction to rofecoxib in a patient with Bartter's syndrome.
    Nucera E, Schiavino D, Pollastrini E, Manna R, Di Lillo M, Buonomo A, Roncallo C, Patriarca G.
    Allergy; 2004 Jul 28; 59(7):788-9. PubMed ID: 15180770
    [No Abstract] [Full Text] [Related]

  • 18. Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Quebec, Canada.
    Rahme E, Toubouti Y, Hunsche E.
    Rheumatology (Oxford); 2006 Jul 28; 45(7):903-10. PubMed ID: 16461440
    [Abstract] [Full Text] [Related]

  • 19. FDA announces changes affecting the marketing of non-steroidal anti-inflammatory drugs.
    FDA Consum; 2005 Jul 28; 39(3):7. PubMed ID: 16127812
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.